Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Refractory Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05100862
What this trial is testing

Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Who this might be right for
Relapsed/Refractory Follicular LymphomaMarginal Zone Lymphoma
BeOne Medicines 799
Testing effectiveness (Phase 2)Ended earlyNCT00295880
What this trial is testing

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 12
Very early researchUnknownNCT05444322
What this trial is testing

RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Who this might be right for
Mantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma
He Huang 18
Large-scale testing (Phase 3)Study completedNCT00265837
What this trial is testing

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 72
Not applicableEnded earlyNCT00952185
What this trial is testing

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more
City of Hope Medical Center 9
Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT03568461
What this trial is testing

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Novartis Pharmaceuticals 98
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT04172246
What this trial is testing

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

Who this might be right for
Mature B-cell Malignancies
BeiGene 55
Early research (Phase 1)Study completedNCT02220842
What this trial is testing

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT02956382
What this trial is testing

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Who this might be right for
Refractory Follicular LymphomaRelapsed Follicular Lymphoma
Georgetown University 24
Early research (Phase 1)Looking for participantsNCT06026319
What this trial is testing

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more
Marcela V. Maus, M.D.,Ph.D. 24
Large-scale testing (Phase 3)WithdrawnNCT04796922
What this trial is testing

To Evaluate Efficacy and Safety of Parsaclisib Plus Either Rituximab or Obinutuzumab in R/R Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) (CITADEL-302)

Who this might be right for
Follicular Lymphoma ( FL)Marginal Zone Lymphoma (MZL)
Incyte Corporation
Testing effectiveness (Phase 2)Active Not RecruitingNCT06492837
What this trial is testing

Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Large-scale testing (Phase 3)Looking for participantsNCT06911502
What this trial is testing

Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Who this might be right for
Follicular Lymphoma
Celgene 400
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT06854159
What this trial is testing

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of California, Davis 34
Testing effectiveness (Phase 2)WithdrawnNCT01238146
What this trial is testing

Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI)
Next Page